Long-term Follow-up for Melanoma Patients

作者: Natasha M. Rueth , Kate D. Cromwell , Janice N. Cormier

DOI: 10.1016/J.SOC.2014.12.012

关键词:

摘要: Cumulative findings support the current National Comprehensive Cancer Network guidelines for surveillance in early-stage melanoma (stages IA–IIA), which recommend lifelong dermatologic with regular comprehensive skin exams, adding imaging studies only if there is clinical suspicion of recurrence.1 Regular examination offers highest diagnostic yield detecting recurrences, additional benefit seen when used patients whom evaluation or symptomatic presentation suggests presence distant disease. However, locally regionally advanced IIB–IIIC), a paucity data to use rigorous, routine following appropriate staging and surgical treatment their disease. Contemporary recommend, on basis low-level evidence (category 2B), that clinicians consider addition CT and/or PET/CT every 3 12 months these patients.1 However, indicate such regimen would result an exceedingly large number performed detect limited surgically treatable recurrences have little impact patient survival. Although likely subset high risk oncologic has potential offer survival benefit, more judicious approach may be equally effective detrimental Such considerations are increasing interest modern era rising health care costs impending limitations resource utilization.

参考文章(95)
John A. Olson, Jr, David P. Jaques, Daniel G. Coit, Wen-Jen Hwu, Staging work-up and post-treatment surveillance of patients with melanoma. Clinics in Plastic Surgery. ,vol. 27, pp. 377- 390 ,(2000) , 10.1016/S0094-1298(20)32734-6
Claus Garbe, A Rational Approach to the Follow-up of Melanoma Patients Cancers of the Skin. ,vol. 160, pp. 205- 215 ,(2002) , 10.1007/978-3-642-59410-6_24
Bryan Burmeister, Joanne F. Aitken, Simon Taylor, Euan Walpole, Bernhard M. Smithers, Andrew Barbour, Clinical practice guidelines for the management of melanoma in Australia and New Zealand Cancer Council Australia; Australian Cancer Network; Ministry of Health, New Zealand. pp. 1- 246 ,(2008)
David H. Harpole, Cheryl M. Johnson, Walter G. Wolfe, Stephen L. George, Hilliard F. Seigler, ANALYSIS OF 945 CASES OF PULMONARY METASTATIC MELANOMA The Journal of Thoracic and Cardiovascular Surgery. ,vol. 103, pp. 743- 750 ,(1992) , 10.1016/S0022-5223(19)34957-8
Lucie Rychetnik, Kirsten McCaffery, Rachael Morton, Les Irwig, Psychosocial aspects of post-treatment follow-up for stage I/II melanoma: a systematic review of the literature Psycho-Oncology. ,vol. 22, pp. 721- 736 ,(2013) , 10.1002/PON.3060
Rebecca Siegel, Elizabeth Ward, Otis Brawley, Ahmedin Jemal, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A Cancer Journal for Clinicians. ,vol. 61, pp. 212- 236 ,(2011) , 10.3322/CAAC.20121
D.L.L. Roberts, A.V. Anstey, R.J. Barlow, N.H. Cox, J.A. Newton Bishop, P.G. Corrie, J. Evans, M.E. Gore, P.N. Hall, N. Kirkham, , U.K. guidelines for the management of cutaneous melanoma. British Journal of Dermatology. ,vol. 146, pp. 7- 17 ,(2002) , 10.1046/J.1365-2133.2001.04614.X
Peter Murchie, Environmental impact of GP-led melanoma follow up. British Journal of General Practice. ,vol. 57, pp. 837- 838 ,(2007)
J.R. Marsden, J.A. Newton-Bishop, L. Burrows, M. Cook, P.G. Corrie, N.H. Cox, M.E. Gore, P. Lorigan, R. MacKie, P. Nathan, H. Peach, B. Powell, C. Walker, Revised UK guidelines for the management of cutaneous melanoma 2010 Journal of Plastic Reconstructive and Aesthetic Surgery. ,vol. 63, pp. 1401- 1419 ,(2010) , 10.1016/J.BJPS.2010.07.006